ReviewNanoscale advances2026
Antioxidant and antibacterial properties of transition metals and metal oxides for medical uses: mechanisms, design strategies, and biomedical perspectives.
Review in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- One-Step Sol-Gel-Fabricated CuZn Alloy Aerogel Enabled by Cu-Zn Bimetallic Synergy for Efficient Antibacterial and Anti-Biofilm Therapy.Gels (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review provides a critical and integrative analysis of transition metal and metal oxide NPs as emerging multifunctional platforms for biomedical applications, with particular emphasis on their dual antioxidant and antibacterial properties. Beyond conventional descriptive approaches, we systematically correlate physicochemical parameters, including particle size, morphology, surface charge, crystallinity, and functionalization, with biological performance, thereby establishing clear structure-activity relationships governing therapeutic efficacy and biosafety. Key transition metals such as Ag, Cu, Se, Ti, Zn, and Fe, along with their oxides, are examined in terms of their mechanistic pathways, including reactive oxygen species (ROS) modulation, metal ion release, membrane disruption, and enzyme-mimetic antioxidant activity. Recent advances in synthesis strategies, particularly green and bioinspired methods, are highlighted as enabling routes for improving biocompatibility, stability, and targeted functionality. Importantly, this review critically discusses the dual role of ROS in mediating both antibacterial action and oxidative stress regulation, offering a unified framework for designing balanced nano-therapeutics. Comparative analyses reveal that materials with strong antibacterial activity often exhibit weaker intrinsic antioxidant capacity, underscoring the need for rational design of hybrid or multifunctional nanoplatforms. Furthermore, key challenges related to cytotoxicity, long-term biosafety, microbial resistance, and clinical translation are comprehensively evaluated. Strategies such as surface engineering, controlled ion release, and synergistic combinations with conventional antibiotics are proposed to overcome these limitations. By bridging fundamental mechanisms with applied biomedical perspectives, this review provides actionable insights for the next generation of safe, effective, and clinically translatable metal-based nanomaterials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.